Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Brumm

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Journal of Animal Science|December 20, 2005
Application of broken-line analysis to assess floor space requirements of nursery and grower-finisher pigs expressed on an allometric basisH W Gonyou, M C Brumm, E Bush, et al.
Neurology|February 6, 2025
α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson DiseaseDavid G Coughlin, Ben Shifflett, Carly M Farris, et al.
NPJ Parkinson'S Disease|October 22, 2022
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohortTanya Simuni, Kalpana Merchant, Michael C Brumm, et al.
Annals of Clinical and Translational Neurology|March 27, 2023
Central and peripheral α-synuclein in Parkinson disease detected by seed amplification assayLana M Chahine, Thomas G Beach, Charles H Adler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2025
Neuronal α-Synuclein Disease Stage Progression over 5 YearsTanya Simuni, Caroline Gochanour, Anuprita R Nair, et al.
Journal of Parkinson'S Disease|July 17, 2023
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease ProgressionMichael C Brumm, Andrew Siderowf, Tanya Simuni, et al.
Neurology|August 5, 2020
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson diseaseLana M Chahine, Thomas G Beach, Michael C Brumm, et al.
Annals of Neurology|April 30, 2026
Return of Individual Research Information in the Parkinson's Progression Markers InitiativeThomas F Tropea, Kathryn Brodkin, Michael C Brumm, et al.
Neurology|August 22, 2022
Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the <i>LRRK2</i> G2019S VariantRachel Saunders-Pullman, Roberto Angel Ortega, Cuiling Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmiaDaniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Journal of Animal Science|December 20, 2005
Application of broken-line analysis to assess floor space requirements of nursery and grower-finisher pigs expressed on an allometric basisH W Gonyou, M C Brumm, E Bush, et al.
Neurology|February 6, 2025
α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson DiseaseDavid G Coughlin, Ben Shifflett, Carly M Farris, et al.
NPJ Parkinson'S Disease|October 22, 2022
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohortTanya Simuni, Kalpana Merchant, Michael C Brumm, et al.
Annals of Clinical and Translational Neurology|March 27, 2023
Central and peripheral α-synuclein in Parkinson disease detected by seed amplification assayLana M Chahine, Thomas G Beach, Charles H Adler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2025
Neuronal α-Synuclein Disease Stage Progression over 5 YearsTanya Simuni, Caroline Gochanour, Anuprita R Nair, et al.
Journal of Parkinson'S Disease|July 17, 2023
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease ProgressionMichael C Brumm, Andrew Siderowf, Tanya Simuni, et al.
Neurology|August 5, 2020
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson diseaseLana M Chahine, Thomas G Beach, Michael C Brumm, et al.
Annals of Neurology|April 30, 2026
Return of Individual Research Information in the Parkinson's Progression Markers InitiativeThomas F Tropea, Kathryn Brodkin, Michael C Brumm, et al.
Neurology|August 22, 2022
Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the <i>LRRK2</i> G2019S VariantRachel Saunders-Pullman, Roberto Angel Ortega, Cuiling Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmiaDaniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Pageof 9